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SUMMARY 40 
 41 
BACKGROUND 42 
Age-associated motor and cognitive deficits increase the risk of falls, a major cause of morbidity and mortality. 43 
Because of the significant ramifications of falls, many interventions have been proposed, but few have aimed 44 
to prevent falls via an integrated approach targeting both motor and cognitive function. We aimed to test the 45 
hypothesis that an intervention combining treadmill training with non-immersive virtual reality (VR) to target 46 
both cognitive aspects of safe ambulation and mobility would lead to fewer falls than would treadmill training 47 
alone. 48 
METHODS 49 
We carried out this randomised, controlled trial at five clinical centres across five countries (Belgium, Israel, 50 
Italy, the Netherlands, and the UK). Adults aged 60−90 years with a high risk of falls based on a history of two 51 
or more falls in the 6 months before the study and with varied motor and cognitive deficits were randomly 52 
assigned by use of computer-based allocation to receive six weeks of either treadmill training plus VR or 53 
treadmill training alone. Randomisation was stratified by subgroups of patients (those with a history of 54 
idiopathic falls, those with mild cognitive impairment, and those with Parkinson’s disease) and sex, with 55 
stratification per clinical site. Group allocation was done by a third party not involved in onsite study 56 
procedures. Both groups aimed to train three times per week for 6 weeks, with each session lasting about 45 57 
min and structured training progression individualised to the participant’s level of performance. The VR system 58 
consisted of a motion-capture camera and a computer-generated simulation projected on to a large screen, 59 
which was specifically designed to reduce fall risk in older adults by including real-life challenges such as 60 
obstacles, multiple pathways, and distracters that required continual adjustment of steps. The primary 61 
outcome was the incident rate of falls during the 6 months after the end of training, which was assessed in a 62 
modified intention-to-treat population. Safety was assessed in all patients who were assigned a treatment. 63 
This study is registered with ClinicalTrials.gov, NCT01732653. 64 
FINDINGS 65 
Between Jan 6, 2013, and April 3, 2015, 302 adults were randomly assigned to either the treadmill training plus 66 
VR group (n=154) or treadmill training alone group (n=148). Data from 282 (93%) participants were included in 67 
the prespecified, modified intention-to-treat analysis. Before training, the incident rate of falls was similar in 68 
both groups (10·7 [SD 35·6] falls per 6 months for treadmill training alone vs 11·9 [39·5] falls per 6 months for 69 
treadmill training plus VR). In the 6 months after training, the incident rate was significantly lower in the 70 
treadmill training plus VR group than it had been before training (6·00 [95% CI 4·36−8·25] falls per 6 months; 71 
p<0·001 vs before training), whereas the incident rate did not decrease significantly in the treadmill training 72 
alone group (8·27 [5·55−12·31] falls per 6 months; p=0·49). 6 months after the end of training, the incident rate 73 
of falls was also significantly lower in the treadmill training plus VR group than in the treadmill training group 74 
(incident rate ratio 0·58, 95% CI 0·36−0·96; p=0·033). No serious training-related adverse events occurred. 75 
INTERPRETATION 76 
In a diverse group of older adults at high risk for falls, treadmill training plus VR led to reduced fall rates 77 
compared with treadmill training alone. 78 
FUNDING 79 
European Commission (FP7 V-TIME-278169)  80 
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INTRODUCTION 81 
Gait impairments and falls are ubiquitous among older adults (roughly >65 years) and patients with many 82 
neurological diseases. About 30% of community-dwelling adults older than 65 years fall at least once per year.1 83 
Among people with mild cognitive impairment, dementia, or Parkinson’s disease, falls are even more common 84 
with 60–80% of individuals reporting falls each year.2 The consequences of falls often are severe, leading to loss 85 
of functional independence, social isolation, institutionalisation, disability, and death.1 Falls also place a huge 86 
burden on health-care systems, accounting for 1−2% of all health-care expenditures in many  high income 87 
countries.3  88 
Most falls occur during walking4 and hence gait impairment is associated with an increased fall risk.5 Falls in 89 
elderly people often occur as a result of tripping and poor obstacle negotiation,6 with the  lower-leg of older 90 
adults passing dangerously close to impediments during walking.7 Obstacle negotiation also relies on cognitive 91 
executive control, and judgment,8 partly explaining why age-related decline in cognitive function is associated 92 
with increased fall risk.9  93 
Various intervention programmes have aimed to reduce fall risk.10 However, despite the increasing recognition 94 
of the importance of cognition, motor, and obstacle negotiation abilities, previous multifactorial interventions 95 
have generally focused on individual risk factors separately, largely ignoring their interdependence. Cognition 96 
and motor aspects might both be targeted, but usually only individually. Growing evidence11−13 and the 97 
increasing recognition of the importance of cognition for safe walking14,15 suggest that a multimodal treadmill 98 
training programme augmented with a computer-simulated non-immersive virtual reality (VR) could improve 99 
both motor and cognitive aspects of fall risk.16 Generally, VR is defined as a high-end-computer interface that 100 
involves realtime simulation and interactions through multiple sensorial channels.16,17 Such an approach can be 101 
used to provide training in a stimulating and enriching environment that targets both motor and cognitive 102 
function, while also providing feedback about performance to assist with learning new motor strategies of 103 
movement. Integrated approaches that concurrently target motor and cognitive contributors to safe 104 
ambulation have not been well-studied. Consistent with existing recommendations,10,18 we postulated that 105 
simultaneously training the motor and cognitive aspects of falls would help to reduce fall rates and ameliorate 106 
fall risk.  107 
We aimed to test the hypothesis that a 6 week programme of treadmill training combined with a VR 108 
component would lead to a lower incidence of falls than would a similar intensity intervention delivered via 109 
treadmill training alone. We investigated this hypothesis in older adults at high risk of future falls based on a 110 
recent history of multiple falls, including people who had idiopathic falls, individuals with mild cognitive 111 
impairment, and people with Parkinson’s disease. 112 
 113 
METHODS 114 
Study Design and Participants 115 
We conducted a prospective, single-blind, randomised controlled trial, with 6 months follow-up at five clinical 116 
centres across five countries (Belgium, Israel, Italy, the Netherlands, and the UK; appendix). The trial was 117 
approved by the medical ethics review committee at each site. Details of the protocol and study design have 118 
been reported previously16 and additional details are available online.  119 
We recruited community-living older adults via flyers, advertising, presentations at local residential and 120 
community senior centres, review of medical records at local outpatient clinics, and word of mouth. After initial 121 
screening by phone, chart review or interview, eligible individuals were invited to participate if they were aged 122 
60−90 years, able to walk for at least 5 min unassisted, on stable medication for the past month, and self-123 
reported two or more falls within 6 months before screening.16 In addition to these criteria, individuals with 124 
mild cognitive impairment were included if they had a score of 0·5 on the Clinical Dementia Rating scale.19 125 
People with Parkinson’s disease were included if they had been diagnosed in accordance with the UK Brain 126 
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Bank criteria, had Hoehn and Yahr stage II–III disease,20 and were taking antiparkinsonian medication (to 127 
maximise patient homogeneity). Individuals were excluded if they had psychiatric co-morbidity (eg, major 128 
depressive disorder as in accordance with DSM IV criteria); history of stroke, traumatic brain injury or other 129 
neurological disorders (other than Parkinson’s disease and mild cognitive impairment, for those groups); acute 130 
lower back or lower extremity pain; peripheral neuropathy; rheumatic and orthopaedic diseases; or a clinical 131 
diagnosis of dementia or severe cognitive impairment (Mini Mental State Exam [MMSE] score21 <21). All 132 
decisions about eligibility were made before randomisation. After undergoing screening to confirm eligibility, 133 
individuals who agreed to participate in the study were asked to provide informed written consent. 134 
 135 
Randomisation and masking 136 
By use of computer-based allocation, participants were randomly assigned to receive either treadmill training 137 
plus VR or treadmill training alone. Due to the expected heterogeneity in fall rates, random assignment to 138 
training arm was stratified by subgroups of patients (ie, older adults with a history of falls, individuals with mild 139 
cognitive impairment, or people with Parkinson’s disease). To ensure similar representation of men and 140 
women, randomisation was also stratified by sex. To minimise the effects of study site bias, all stratification 141 
procedures were done per clinical site. Allocation was done by the study contract research organization 142 
(Advanced Drug and Device Services [ADDS], Brno, Czech Republic), a third partly not involved in study 143 
procedures on site. Outcome assessors and monitors were masked to study group assignment. 144 
 145 
Procedures 146 
Participants aimed to train three times per week for 6 weeks in both groups, with each session lasting about 45 147 
minutes. Training was similar between arms, except for the computerised simulation component for those 148 
subjects who were assigned to treadmill training plus VR. A trainer was present at all training sessions.  149 
In the treadmill training plus VR intervention, the system included a camera for motion capture (a modified 150 
Microsoft Kinect for Windows, Microsoft, Redmond, WA, USA) and a computer generated simulation. The 151 
Microsoft Kinect camera was modified to include an additional camera to also distinguish between the feet. 152 
The camera recorded the movement of the participant’s feet while they walked on the treadmill. These images 153 
were projected to the participant in real-time on a large screen during the training, enabling the participants to 154 
see their feet walking within the simulation. The virtual environment was specifically designed to reduce fall 155 
risk in older adults; it included real-life challenges, consisting of obstacles, multiple pathways, and distracters 156 
that necessitated continual adjustment of steps (figure 1).11,16 The virtual environment imposed a cognitive 157 
load that demands attention, planning, dual tasking, response selection, and processing of rich auditory and 158 
visual stimuli that involve several perceptual processes. Visual and auditory feedback of performance and 159 
results were provided to participants both during training and as a summary at the end of the sessions. Training 160 
progression was structured in accordance with a prespecified plan for progression and was based on increasing 161 
both motor and cognitive challenges that were individualised to the participant’s level of performance.11,16 162 
Progression of the intervention was modulated via the speed of the treadmill, the duration of the walking 163 
bouts within a given training session, and the size and frequency of the virtual obstacles and the distractors.  164 
Treadmill training alone was chosen as the active control intervention because of its positive effect on 165 
mobility22 and to allow for evaluation of the added value of the VR component. As in the treadmill training plus 166 
VR intervention, training progression was based on individual performance by increasing the duration of 167 
walking and walking speed in a standardised, prespecified fashion.16 The amount of time spent with the trainer 168 
was similar to that in the experimental group and training followed similar guidelines, which detailed the time 169 
and steps to progression in a well-defined manner.  170 
Fall rate was recorded during the 6 months after the end of training. A fall was defined as “an unexpected 171 
event in which the participant comes to rest on the ground, floor or lower level”.23 Because of the importance 172 
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of this outcome, several options were provided for the recording of fall events and to maximise the accuracy of 173 
reporting. Participants received a falls calendar, which they were provided as a paper version, web-based 174 
calendar, or a smartphone application (appendix) in accordance with their preference. Information logged in 175 
the online or smartphone-based calendar was automatically uploaded to a database, whereas the paper 176 
calendars were posted back to the sites at which participants were recruited each month via pre-addressed 177 
envelopes. Research staff contacted all participants every month to maximise compliance. The falls database 178 
was checked, reviewed, and locked before intervention group assignment was unmasked.  179 
Other outcomes were assessed at sessions 1 week before training and 1 week after training to examine acute 180 
effects, and 1 month and 6 months after training to examine retention effects. Gait speed and gait variability 181 
(using a Zeno instrumented walkway and PKMAS software, Havertown, PA, USA) were measured during usual 182 
walking and while participants negotiated physical obstacles. Inertial measurement units placed on both ankles 183 
and the lower back (Opal, APDM, Portland, OR,USA) were used to quantify foot clearance during obstacle 184 
negotiation.24 Endurance was assessed with the 2 min walk test. The Short Physical Performance Battery (SPPB) 185 
was used to assess balance and mobility in the laboratory setting, whereas the Physical Activity Scale for the 186 
Elderly questionnaire was used to assess everyday activity.16 Attention and executive function were assessed 187 
by use of a computerised neuropsychological test battery (NeuroTrax Corp, Medina, Modiin, Israel).25 Health 188 
related quality of life was measured with the SF-36 Health Survey. Disease severity in the patients with 189 
Parkinson’s disease was classified in accordance with the motor part of the Unified Parkinson’s Disease Rating 190 
Scale (UPDRS-III).26  191 
All outcome measures (ie, falls and secondary outcome measures) were assessed by blinded assessors. Falls 192 
were recorded without knowledge of training group. An assessor at each site, who was masked to the 193 
intervention group allocation, did all assessments at roughly the same time of day to avoid variability of 194 
performance due to time or medication intake cycles. For the participants with Parkinson’s disease, all tests 195 
were done in the practical self-reported on-medication state (roughly 1 h after medication intake).  196 
Deviations from the original protocol16 were widening of the age range from 60−85 years to 60−90 years to 197 
allow for inclusion of additional participants who could benefit from the interventions; lowering of the MMSE 198 
cutoff score from more than 24 to more than 21 to include participants with a wider range of cognitive 199 
impairments; and removal of the exclusion cutoff based on the New Freezing of Gait questionnaire, because 200 
the consortium realised that the existence of freezing of gait did not negate training.27 201 
 202 
Outcomes 203 
The primary outcome measure was the incident rate of falls in the 6 months after the end of training. Falls that 204 
occurred up to 182 days after training were included in the primary analysis. Secondary outcome measures 205 
investigated the effects of the interventions on known measures of fall risk, as previously reported.16 These 206 
measures included gait speed and variability, foot clearance during obstacle negotiation, endurance, balance 207 
and mobility in the laboratory setting and in everyday activity, attention and executive function, and health-208 
related quality of life. Additional secondary outcomes not reported in this Article include the effects of the 209 
interventions on the falls efficacy scale (FES-I), the Four Square Step Test, the mini-Balance Evaluation System 210 
Test, the Trail Making Test, verbal fluency, other measures of cognitive function (eg, memory), accelerometer-211 
derived estimates of physical activity, and the user satisfaction questionnaire. Safety was assessed in terms of 212 
adverse events, which were defined as any untoward medical occurrence, unintended disease, or injury of the 213 
participants whether or not they were related to the intervention.16 214 
 215 
Statistical analysis 216 
Based on previous evidence,28 we carried out an a-priori power analysis assuming that the fall incident rate 217 
after the intervention in the treadmill training alone group would be three falls per year. Assuming a 40% 218 
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reduction for the experimental group during the 6 month followup, 28 166 participants (83 in each group) 219 
would be needed for 80% power to detect significant differences (α=0·05) between the treatment groups 220 
assuming non-inferiority with moderate correlation among covariates (R²=0·50). If we aimed for a more robust 221 
90% power and assumed 20% loss to follow-up, we would need to recruit 137 participants per group. To 222 
enhance the ability to explore the effects of the intervention on fall incidence, we aimed to recruit 300 223 
participants overall, distributed across the five study centres.  224 
For the primary outcome, we estimated fall incident rates in the 6 months after training by use of negative 225 
binomial regression and a modified intention-to-treat analysis (appendix). The incident rate of falls and incident 226 
rate ratio (IRR), with 95% CIs, were calculated for comparisons between groups by use of negative binomial 227 
regression models. Training group was the fixed factor and the number of days after training with recorded 228 
falls data—ie, a measure of exposure—was an offset variable, therefore accounting for different observation 229 
periods for different participants. It is possible that participants reported more than one fall on a given day, but 230 
the model treated each participant with equal weights. Multiple falls on one day were counted as the number 231 
that occurred. We used age and sex as covariates because falls are more common in women and fall risk 232 
increases with age.29−31 Baseline characteristics were compared between groups and we examined the effects 233 
of any characteristics that were marginally (p<0.10) different between the two groups. The level of significance 234 
was set at 5%. Prespecified secondary analyses assessed the change in falls status and explored the fall rates in 235 
the three subgroups of participants (ie, people with idiopathic falls, individuals with mild cognitive impairment, 236 
and people with Parkinson’s disease). We analysed secondary outcome measures with generalised linear 237 
mixed-effects models (appendix). As prespecified, we checked the effect of study site in all of the primary and 238 
secondary analyses, by including site as a covariate; the effect was not significant and site was therefore not 239 
included in any of the final models (data not shown). We referred to the modified intention-to treat population 240 
used for the efficacy analyses as the full analysis set, which adhered as closely to the intention-to treat 241 
principle as was possible. The full analysis set included all participants who underwent randomisation, satisfied 242 
eligibility criteria, had at least three training sessions, and had any assessments during the 6 month follow-up 243 
period. According to the intention-to-treat principles, any participants who were randomly assigned to a group 244 
but discontinued the study before 6 months of follow-up were included into the full analysis set. Missing data 245 
resulting from dropouts, technical problems, and human errors were not imputed. The analysis plan was pre-246 
specified in the protocol and the statistical analysis plan. The safety analysis included all participants who 247 
underwent randomisation and is presented as absolute and relative frequency counts, with comparisons 248 
between groups. All statistical analyses were done with SAS version 9.4. The contract research organisation, 249 
ADDS, conducted data monitoring and were also responsible for the database and for locking the database 250 
before unblinding. 251 
This study is registered with ClinicalTrials.gov, number NCT01732653. 252 
 253 
Role of the funding source  254 
The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or 255 
writing of the report. All authors had full access to the data. The corresponding author had final responsibility 256 
for the decision to submit for publication. 257 
 258 
Results 259 
661 individuals were screened. The most common reason for ineligibility was fewer than two falls in the 6 260 
months before the study. Between Jan 6, 2013, and April 3, 2015, 302 participants were recruited who met the 261 
inclusion criteria, consented to participate, and were then randomly assigned to one of the training groups 262 
(148 to treadmill training alone and 154 to treadmill training plus VR). 16 (5%) participants dropped out before 263 
starting training, and four (1%) participants did not complete the minimum training sessions needed, leaving 264 
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282 participants (136 in the treadmill training alone group and 146 in the treadmill training plus VR group) who 265 
completed training and were included in the full analysis set (figure 2; appendix). Participants in the two 266 
training arms were well-matched with respect to baseline characteristics (table 1). The distribution of the three 267 
participant subgroups (130 with Parkinson’s disease, 43 with mild cognitive impairment, and 109 people with 268 
idiopathic falls) was similar between the two groups (64 individuals in treadmill training group vs 66 in 269 
treadmill training plus VR group with Parkinson’s disease; 20 vs 23 with mild cognitive impairment; and 52 vs 270 
57 with idiopathic falls). The methods of reporting falls used by the participants were similar between groups 271 
(p=0·822; data not shown), as was compliance with the interventions (p=0·350); of 18 sessions, the mean 272 
number of completed sessions was 16·62 (SD 1·78) in the treadmill training plus VR group and 16·82 (1·81) in 273 
the treadmill training group. Overall, the falls incident rate before the intervention was 11·34 falls (95% CI 274 
9·63−13·34) per 6 months. 275 
 276 
Before training, incident rates were similar (p=0·29) between the training groups (table 2). After training, the 277 
incident rate for all participants was 7·10 falls (95% CI 5·51−9·14) per 6 months, which was a significant 278 
reduction compared with before training (p<0·0001). In the treadmill training plus VR group, the post-training 279 
incident rate was 6·00 falls (95% CI 4·36−8·25) per 6 months (p<0·001 compared with the 6 months before 280 
training). In the treadmill training group, the incident rate decreased to 8·27 falls (95% CI 5·55−12·31) per 6 281 
months, but this reduction was not significant (p=0·49 compared with the 6 months before training). Similarly, 282 
the incident rate was lower after training in the treadmill training plus VR group than in to the treadmill 283 
training alone group (IRR 0·58, 95% CI 0·36−0·96; p=0·033; figure 3 and table 2), showing a significant 284 
advantage for treadmill training plus VR compared with treadmill training. Adjustment for MMSE scores did not 285 
affect the incident rate ratio (data not shown).  286 
Before training, secondary outcome measures were similar) between the two training groups (table 3). Many 287 
of the secondary outcomes improved in both training groups after training, whereas other outcomes (gait 288 
speed variability, leading foot clearance, SPPB balance, SPPB gait, SF-36 physical total, and SF-36 mental total) 289 
improved more in the treadmill training plus VR group than in the treadmill training group (table 3).  290 
Immediately after training, gait speed under usual and obstacle negotiation walking conditions improved (both 291 
p<0·0001) in both training groups. Gait variability during obstacle negotiation was significantly lower (ie, 292 
better) in the treadmill training plus VR group than in the treadmill training group. Obstacle clearance was 293 
greater after training in the treadmill training plus VR group than in the treadmill training group. Cognitive 294 
function outcomes improved similarly in both training groups. Scores on the SPPB also improved in both 295 
groups, however, significantly larger gains for the gait and balance components were achieved in the treadmill 296 
training plus VR group than in the treadmill training group. Conversely, self-reported daily life activity did not 297 
change after training in either arm (p=0·128 in treadmill training group; p=0·211 in treadmill training plus VR 298 
group).  299 
Several measures were better in the treadmill training plus VR group than in the treadmill training group, even 300 
at the 6 month follow-up. These outcomes included endurance, obstacle clearance, mobility (ie, SPPB scores), 301 
and quality of life (table 3). Training effects at the end of training and the end of follow-up were generally 302 
larger in the treadmill training plus VR group among the patients with Parkinson’s disease and the participants 303 
with idiopathic falls (effect sizes r=0·08−0·99); in the subgroup with mild cognitive impairment, the differences 304 
between treadmill training plus VR and treadmill training alone were less consistent, possibly because of the 305 
sample size (appendix). Variability in the Parkinson’s disease group might be related to the differences in 306 
phenotype or disease manifestation within each of the groups.  307 
28 adverse events were reported overall, with 24 occurring in participants who completed a minimum of three 308 
training sessions and were thus included in the analysis: all adverse events led to discontinuation. Of the 28 309 
adverse events, there were five serious adverse events, which consisted of one death from natural causes 310 
(treadmill training group), one stroke (treadmill training plus VR group), one head injury resulting from a car 311 
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accident (treadmill training plus VR group) and two myocardial infarctions (treadmill training group). Minor 312 
adverse events included exacerbated orthopaedic-related pain or arthritis (four participants in the treadmill 313 
training plus VR group vs five in the treadmill training group), herpes-zoster (one vs zero), rhabdomyolysis (zero 314 
vs one), and pneumonia (one vs one). Eight participants sustained a fall during the training period, preventing 315 
them from returning to training. All of these falls occurred outside of the clinic, in the home or community (five 316 
participants in the treadmill training group vs three in the treadmill training plus VR group). All adverse events 317 
were investigated and none were deemed to be caused by the interventions. The frequency of these events 318 
was similar between the training arms (14 adverse events in each training group).  319 
In prespecified exploratory analyses, we examined the falls incident rate after training in the three participant 320 
subgroups. Among the participants with Parkinson’s disease, the incident rate was lower in the treadmill 321 
training plus VR group than in the treadmill training group (IRR 0·45, 95% CI 0·24−0·86; p=0·015) and this effect 322 
persisted after adjusting for disease severity (0·47, 0·25−0·89; p=0·021). Conversely, incident rate after training 323 
did not differ significantly between groups among the people with idiopathic falls (p=0·10) or the participants 324 
with mild cognitive impairment (p=0·99). The lack of effect among the people with idiopathic falls might be 325 
related to an imbalance in pretraining values (appendix).  326 
We conducted a prespecified secondary analysis of falls status (ie, whether a participant had ≥2 falls in a given 327 
time period). Before training, all participants could be classed as having had multiple falls, as per the inclusion 328 
criterion of at least two falls in the 6 months before the study. After training, 171 (61%) of 282 participants 329 
reported no falls or only one fall and were therefore no longer classed as having multiple falls (table 2). This 330 
change in falls status occurred in all three subgroups and in both training groups (all p<0·0001). The greatest 331 
change in falls status was in subgroups of participants with mild cognitive impairment and the people with 332 
idiopathic falls; only 34 (22%) of these 152 participants (12 [28%] of 43 participants with mild cognitive 333 
impairment and 22 [20%] of 109 participants with idiopathic falls) had multiple falls during the 6 months after 334 
the intervention. Among the 130 participants with Parkinson’s disease, 77 (59%) were defined as having had 335 
multiple falls after training, a significantly smaller proportion than before training (p<0·0001).  336 
Results on the analysis of the additional secondary outcome measures (ie, FES-I, the Four Square Step Test, the 337 
mini-Balance Evaluation System Test, the Trail Making Test, verbal fluency, other measures of cognitive 338 
function, accelerometer-based estimates of physical activity, and the user satisfaction questionnaire) will be 339 
reported in future publications.  340 
 341 
Discussion 342 
To our knowledge, this study is the first to investigate the effects of an intensive treadmill-based intervention 343 
with and without a VR component on fall rates in an older adult population with a high risk of falls. Both 344 
treadmill training interventions significantly improved markers of fall risk and fall rates were lowered for both 345 
interventions compared with values from before training, emphasizing the therapeutic value of the active 346 
control intervention (ie, treadmill training alone). Nonetheless, comparisons within the training groups showed 347 
that the reduction in fall rates was only significant in the treadmill training plus VR group and not in the 348 
treadmill training group. Consistent with this finding, a direct comparison of the two training groups showed 349 
that the treadmill training plus VR intervention had a significant, positive effect on the incident rate of falls, the 350 
primary outcome, and fall risk (gait variability during obstacle negotiation and obstacle clearance), improving 351 
both to a larger degree than that seen in those who trained on the treadmill without the virtual reality 352 
component. In the treadmill training plus VR arm, the fall incident rate decreased from 11·92 falls per 6 months 353 
before training to 6·00 falls per 6 months after training, showing the ability of this multimodal approach to 354 
substantially reduce the number of falls in this high-risk population.  355 
Many older adults are deconditioned, so it is not surprising that the intensive treadmill training was associated 356 
with improved outcomes in our high-risk participants, possibly by facilitating more effective motor control. This 357 
finding concurs with results from metaanalyses on the effect of exercise on fall risk in older adults and patients 358 
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with Parkinson’s disease.28,33 Nonetheless, the rate of falls after training was 42% lower in the treadmill training 359 
plus VR arm than in the active control group of treadmill training alone. The added value of the VR component 360 
might be explained by the nature of the training. The motor-cognitive intervention provided by the VR 361 
implicitly trained obstacle negotiation strategies in a complex, enriched environment that requires focused 362 
attention and planning.11 Executive function and attention have important roles in the regulation of gait, 363 
especially in complex situations such as obstacle negotiation.34,35 Although the cognitive outcome measures 364 
were not sensitive enough to detect differences between training groups, everyday activities such as obstacle 365 
avoidance, which do require cognitive function, improved to a larger extent with the treadmill training plus VR 366 
intervention than they did with treadmill training alone. Training in the VR environment might have enhanced 367 
performance during attention demanding and challenging situations, thereby contributing to real-world fall 368 
avoidance during the 6 month follow-up period.  369 
This observation is supported by the results of the secondary outcomes. After training, participants in the 370 
treadmill training plus VR group had lower (ie, better) gait variability during obstacle negotiation, and greater 371 
obstacle clearance than did those in the treadmill training group. Both gait variability and clearance amplitude 372 
are important measures of obstacle negotiation.7,36 These are skills that could be regarded as training-specific 373 
gains, directly related to the intervention given that obstacle negotiation was trained in the VR. Still, it is 374 
important to note that participants were trained with virtual obstacles and the gains reported here were 375 
measured in the realworld, during over-ground walking. Most secondary outcomes improved in both training 376 
arms from before training to the end of training, reflecting the immediate training effects. However, retention 377 
effects were more common in the treadmill training plus VR group, especially for motor and motor-cognitive 378 
functions (eg, gait, obstacle negotiation, physical performance), suggesting that a learning effect might have 379 
contributed to the observed decrease in fall risk and fall frequency. This possibility is consistent with previously 380 
reported long-term training effects on fall risk achieved with other approaches.37,38  381 
Results from several studies have shown that interventions that enhance cognitive skills lead to improvements 382 
in fall risk factors.39,40 Additionally, subsequent studies have examined the use of combined motor-cognitive 383 
interventions to reduce fall risk in older adults, with conflicting findings. Eggenberger and colleagues12 384 
investigated the efficacy of two multicomponent cognitive–physical intervention programmes on fall risk 385 
mediators and fall frequency in older adults without cognitive impairments. Motor–cognitive training 386 
approaches were superior for improving fall risk mediators such as dual-task cost and gait variability compared 387 
with a similar intensity physical training intervention. However, they found no between-group difference in fall 388 
frequency at 6 months after the intervention. Fu and colleagues,13 examined the effectiveness of the Wii Fit 389 
balance board (Nintendo, Kyoto, Japan) for reducing fall risk and incidence of falls in 60 nursing home 390 
residents. At 12 months after the intervention, the fall incidence rate was reduced in the group that trained 391 
with the Wii Fit balance board compared with a conventional exercise group, with the intervention showing 392 
efficacy even in frail older adults. Our findings are consistent with these preliminary observations and further 393 
support the notion that a combined motor-cognitive intervention could be beneficial to reduce fall rates in 394 
older adults and those with neurodegenerative conditions. Fu and colleague’s findings and ours warrant 395 
further research and clinical implementation.  396 
Our results suggest that treadmill training plus VR training has an advantage over treadmill training alone, 397 
especially in people with Parkinson’s disease. For this subgroup, training with virtual reality reduced the risk of 398 
falls by nearly 60% (IRR 0·45) more than in the treadmill training intervention. This is noteworthy given the high 399 
fall rates in patients with this neurodegenerative disease.2 It is possible that people with Parkinson’s disease 400 
benefited most because their baseline rate of falls was highest. Another explanation could be that falls 401 
improved particularly in this subgroup because the pathophysiology of falls in Parkinson’s disease usually 402 
involves the interplay between motor and cognitive deficits; both domains were clearly affected among the 403 
participants with Parkinson’s disease in this study, and both domains were improved by the treadmill training 404 
plus VR training. By contrast, both training interventions reduced fall risk and improved falls status in the older 405 
adults and individuals with mild cognitive impairment subgroups. Possibly, the underlying cause of falls in these 406 
subgroups more heavily involved motor components and hence both treatment approaches were effective. 407 
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Alternatively, based on the lower reported fall frequency rate and better motor function compared with the 408 
participants with Parkinson’s disease (appendix), the motor-cognitive training might not have been sufficiently 409 
tailored for these participants to produce differences between training groups in these two subgroups. 410 
Nonetheless, we wish to emphasise that although fall rates and falls status improved similarly in the treadmill 411 
training plus VR group and the active control group among the participants with mild cognitive impairment and 412 
individuals with idiopathic falls, there were still advantages to treadmill training with VR in terms of the effects 413 
on the fall risk measures (appendix). The relatively small sample size of individuals with mild cognitive 414 
impairment suggests that these subgroup-specific results need to be interpreted cautiously. It appears that the 415 
participants with idiopathic falls in both training groups benefited from the interventions, when comparing 416 
pretraining to post-training values with no differences between the training arms. However, it also seems that 417 
the rates of falls at baseline were different in this subgroup. Because of the inadequate power for the subgroup 418 
analyses and the problems of recall bias when using retrospective recall to estimate the number of falls over 6 419 
months, it is possible that the lack of difference between the training arms truly reflects no added value for the 420 
VR on fall rates in this population or alternatively, this could be an artifact of the prebaseline differences in fall 421 
rates. This finding should be further explored.  422 
The present study has several limitations. Both the experimental and control groups received active intensive 423 
treatment and we cannot assess the benefit of each treatment compared with no intervention. However, it is 424 
likely that a comparison to usual care would reveal an even larger impact given that usual care is often less 425 
intensive and focuses on general health, and few previous intervention studies have contrasted active 426 
interventions.28 The study was not powered to detect differences between the two training arms in the 427 
subgroups. Thus, comparisons among the subgroups should be considered as being hypothesis-generating 428 
rather than hypothesis testing. Information about falls before training was based on a self-reported estimate 429 
for the previous 6 months, which introduces well-known recall bias.41 To address this shortcoming, for the 430 
primary outcome, we compared differences between training arms based only on falls recorded after the 431 
intervention. Because of the nature of the study design, we cannot fully rule out the possible effect of 432 
regression to the mean on some of the secondary analyses and in the estimation of the reduction in fall rates 433 
compared to values before training. However, given that the participants in the two intervention arms were 434 
well-matched for all of the outcomes at baseline and that study participants were randomly allocated to 435 
comparison groups, the responses from both intervention arms were likely to be equally affected by regression 436 
to the mean. Questions about longer-term follow-up, the motor learning process during the training, and 437 
comparisons to other types of interventions need to be addressed in follow-up work. Future studies should also 438 
include a formal cost-benefit analysis. In the meantime, we note that the additional costs of treadmill training 439 
plus a VR component (<€4000 for a simple clinical setup) compared with treadmill training alone are minimal 440 
(the cost of the computer, screen, safety harness, and platform are relatively low for medium-income 441 
countries) and that treadmills are widely available. Although personalized supervision was used in the our 442 
study, such supervision is probably not necessary in everyday practice, for which group instruction might be 443 
sufficient, enabling highintensity, safe, and engaging training with minimal instructor assistance.42 Additionally, 444 
it will be important to examine whether treadmill training plus VR can be used as part of a therapeutic 445 
prevention package to treat fall risk before falls become common and before any injuries occur. Although 446 
general exercise enhances cognition,43 further investigation is also needed to better  understand the similar 447 
effect of both training groups on cognition and whether improvements differ between subtypes of mild of 448 
cognitive impairment. However, the intervention was safe, the high retention rate (81%) shows the 449 
engagement and adherence of the subjects, and the very few adverse events that occurred were deemed to be 450 
unrelated to training. We found no differences between the five clinical sites, underscoring the fidelity of the 451 
approach used, its feasibility, and broad applicability. Finally, the inclusion of older adults with diverse 452 
characteristics supports the generalisability of this practical approach. 453 
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RESEARCH IN CONTEXT 601 
Evidence before this study 602 
We searched PubMed and the Cochrane Database for relevant articles published from Jan 1, 1980, to Dec 31, 603 
2015. We used the keywords falls, prevention training, aging, older adults, and Parkinson's disease. The search 604 
resulted in the identification of several reviews and meta-analyses. Many intervention programs based on 605 
reported multiple risk factors have been proposed and evaluated. However, despite the extensive knowledge 606 
on fall risk obtained in recent years, there is no consensus as to the most efficacious or optimal treatment 607 
approach.  To date, the impact on fall risk from common treatment approaches tends to be small and the 608 
reported changes are largely focused on motor aspects with limited long-term retention. Furthermore, most 609 
trials compared a fall prevention intervention with no intervention or an intervention not expected to reduce 610 
falls, stressing the need for studies with an active control comparison.  A paucity of studies targeting 611 
participants with cognitive deficits was also noted. In addition, recent work on the role of the central nervous 612 
system in mobility calls for multi-modal interventions that target multiple pathways simultaneously, using an 613 
adaptive and individually tailored treatment in an enjoyable and challenging environment to increase 614 
adherence and maintenance. The present study addresses these gaps in previous fall risk interventions. 615 
Added value of this study 616 
This study is the largest randomized control trial conducted using a multi-modal, motor-cognitive training 617 
paradigm with virtual reality to reduce falls in older adults. Advantages of this approach include the fact it 618 
provides training in a more engaging, stimulating and enriched environment than traditional rehabilitation,  619 
gives feedback about performance to the subject to facilitate the learning of new motor strategies of 620 
movement, and simultaneously and seamlessly addresses motor and cognitive aspects of fall risk that are 621 
critical to safe ambulation. The multi-modal approach is compared to an active comparison intervention, 622 
namely a matched treadmill training program but  without virtual reality. The results showed that treadmill 623 
training alone and treadmill training with virtual both reduced the risk of falls. At the same time, the multi-624 
modal, motor-cognitive training approach decreased falls and fall risk to a larger degree than that seen in the 625 
active control comparison group.  626 
Implications of all available evidence 627 
Falls are wide-spread and common among older adults. There is, however, ample evidence that fall rates and 628 
risk can be reduced, even among older adults with an especially high risk of falls, such as people with 629 
Parkinson’s disease. Multi-modal therapies that target motor and cognitive function may have further added 630 
value, beyond an intervention that focuses on motor control alone. Interventions that combine technology, 631 
mobility training, and cognitive remediation to reduce the risk of falls and enhance mobility can apparently 632 
reduce fall rates and fall risk among the elderly, even among those with chronic disease and cognitive deficits. 633 
Targeting cognitive aspects of safe ambulation together with mobility using treadmill training is feasible, with 634 
minimal added costs compared to treadmill training alone, and with high levels of compliance, even in patients 635 
with neurodegenerative diseases and other high-risk populations, supporting a possible broad clinical 636 
translation of the results.  A game-like approach based on virtual reality can apparently be applied to engage 637 
subjects, motivate compliance, and reduce fall rates in a diverse group of older adults.  638 
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Table 1: Subject characteristics* 
 TT  
(n=136) 
TT+VR  
(n=146) 
P-value 
Age [yrs] 73·3±6·4 
73·0 (61·0 - 89·0) 
74·2±6·9 
74·0 (60·0 - 89·0) 
0·244 
Gender [M / F] 
  
84 / 52 
61·8% / 38·2% 
98 / 48 
67·1% / 32·8% 
0·625 
Education [yrs] 
  
12·9±3·9 
13·0 (3·0 - 30·0) 
13·1±4·00 
13·0 (5·0 - 22·0) 
0·671 
Fall history [number of falls in 6 
months prior to the intervention]   
10·7±35·6 
2·5 (2·0 - 260·0) 
11·9±39·5 
3·0 (2·0 - 300·0) 
0·786 
Mini Mental State Examination 
[max 30] 
28·2±1·7 
28·5 (24·0 - 30·0) 
27·8±1·8 
26 (22·0 - 30·0) 
0·092 
Number of Prescription 
Medications 
6·1±3·5 
6 (1-19) 
6·3±3·9 
5 (1- 20) 
0·703 
Gait speed during 2 Minute Walk 
test [m/sec]  
1·02±0·27 
1·04 (0·21- 1·70) 
1·02±0·28 
1·04 (0·21- 1·70) 
0·662 
*Entries are Mean±SD and Median (Min-Max) or n and %.  The number of prescription medications was used as a proxy for general 642 
health and is known to be associated with fall risk. P-values reported here are based on t-tests.  See supplementary material Table 1 for 643 
the subject characteristics among the elderly fallers, the participants with MCI, and the people with PD.  644 
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Table 2: Secondary outcome measures prior to and after training 
P value 
Subgroup 
P value 
Time 
P value 
Arm 
Difference of Least 
Square mean and CI 
LS mean (95% CI) 
TT+VR TT Assessment Outcome measure Domain  
0·005 <0·001 0·480 0·006  (-0·027, 0·004) 1·00 0·99 Pre-training Gait speed usual walking 
(m/sec) 
Gait 
-0·012 (-0·045, 0·022) 1·06time 1·07time Post-training 
-0·0003 (-0·035, 0·003) 1·05time 1·05time 6M follow-up 
0·003 0·011 0·321 0·039 (-0·509, 0·588) 5·24 5·21 Pre-training Gait speed variability 
usual walking (%) -0·121 (-0·673, 0·432) 4·71time 4·83 Post-training 
-0·609 (-1·194, -0·025) 4·91 5·23 6M follow-up 
0·023 <0·001 0·320 0·003 (-0·031, 0·036) 0·95 0·94 Pre-training Gait speed obstacle 
negotiation (m/sec) 0·014 (-0·019, 0·048) 1·02time 1·00time Post-training 
0·022 (-0·014, 0·046) 0·98time 0·98time 6M follow-up 
0·0203 <0·001 0·018  0·156 (-1·149, 1·461) 16·78 16·62 Pre-training Gait speed variability 
obstacle negotiation (%) -2·044 (-3·363,-0·725) 13·92time; arm 15·97time Post-training 
-0·937 (-2·332, 0·456) 13·90time 14·84 6M follow-up 
0·8443 0·040 0·002 -0·163 (-1·262, 0·934) 32·22 32·38 Pre-training Leading foot clearance 
from obstacle during  
walking (cm) 
1·244 (-0·055, 2·544) 33·74time 32·03  Post-training 
2·498 (1·130,  3·867) 33·06arm 30·56time 6M follow-up 
0·0782,3 <0·001 0·077 -0·730 (-4·057, 3·911) 124·46 124·53 Pre-training 2 Minute walk test (m) 
4·001 (0·011, 8·003) 132·49time; arm 128·48time Post-training 
2·301 (-0·027, 9·536) 126·77 124·47 6M follow-up 
0·042 <0·001 0·398 -0·252  (-1·973, 6·476) 92·39 92·42 Pre-training Executive function index Cognition 
-0·722 (-2·277, 0·831) 94·07time 94·79time Post-training 
-0·701 (-2·327, 0·923) 95·36time 96·05time 6M follow-up 
0·034 <0·001 0·608 -0·261 (-2·362, 1·838) 91·57 91·83 Pre-training Attention index score 
-0·365 (-2·482, 1·752) 93·26 93·63time Post-training 
0·257 (-1·958, 2·474) 95·12time 94·86time 6M follow-up 
0·054 <0·001 0·078 0·073 (-0·262, 0·410) 8·88 8·81 Pre-training Short Physical 
Performance Battery 
(SPPB) total  
Mobility 
0·151 (-0·186, 0·488) 9·61time 9·46time Post-training 
0·377 ( 0·025, 0·729) 9·17arm 8·79 6M follow-up 
0·017 
 
 
<0·001 
 
 
0·992 
 
 
0·033 (-0·159, 0·227) 2·07 2·04 Pre-training SPPB chair rise 
 
 
 
-0·059 (-0·252, 0·135) 2·37time 2·43time Post-training 
0·033 (-0·169, 0·236) 2·18 2·15 6M follow-up 
19 
 
0·0323 <0·001 0·030 0·003 (-0·176, 0·182) 3·23 3·22 Pre-training SPPB balance 
0·078 (-0·101, 0·258) 3·41time 3·33time Post-training 
0·294 ( 0·106, 0·483) 3·39time; arm 3·09 6M follow-up 
0·2383 <0·001 0·032 0·037 (-0·089, 0·164) 3·55 3·52 Pre-training SPPB gait 
0·134 ( 0·007, 0·262) 3·80time; arm 3·68time Post-training 
0·075 (-0·057, 0·208) 3·60 3·53 6M follow-up 
0·410 0·281 0·126 0·988 (-9·023, 11·001) 102·8 101·7 Pre-training Physical Activity Scale for 
the Elderly (PASE) 6·350 (-3·793, 16·493) 102·2 95·8 Post-training 
2·482 (-8·084, 13·049) 106·1 103·6 6M follow-up 
0·0081 <0·001 0·033 0·061  (-2·839, 2·962) 55·82 55·76 Pre-training SF-36 Physical total Quality of 
Life 2·768  (-0·171, 5·707) 60·56time 57·73 Post-training 
2·317  (-0·749, 5·383) 58·04 55·73 6M follow-up 
0·4941 0·072 0·041  -0·358 (-3·280, 2·564) 68·96 69·32 Pre-training SF-36 Mental total 
1·924  (-1·037, 4·886) 72·35time 70·43 Post-training 
2·468  (-0·629, 5·567) 72·41time 69·94 6M follow-up 
For the sake of brevity, results at the 1 month time point are not shown. In general, values at this time point were in between those measured at the post and 6 month testing 
assessments. Pre-training, these secondary outcome measures were similar in the TT+VR and TT arms (p>0·12).  The three p-values in the right most columns indicate main effects for 
training arm, time, and subject subgroup (e.g., MCI vs. PD) for each of the outcome measures.  *1,2,3 indicate significant changes observed within the elderly, MCI or PD subgroups, 
respectively. SPPB: Short Physical Performance Battery. Values entered are the age and gender corrected least squares estimates of the mean. MCI: mild cognitive impairment; PD: 
Parkinson’s disease; CI: confidence interval. For the SF-36, the summary indices for physical and mental health are reported. A significant arm X time interaction effect was observed for 
leading foot clearance. This measure became worse (smaller) in TT and better in TT+VR after training.  time indicates a significant within training arm effects of time, compared to pre-
training values.  arm indicates a significant effect of TT+VR vs. TT. 
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Table 3: Falls incident rates in the 6 months prior to training and the 6 months post-training among all study 
participants and within each subgroup. 
 Pre-training Post-training 
All subjects Elderly MCI PD All subjects Elderly MCI PD 
Total # of 
falls 
TT 
TT+VR 
1456 
1741 
168 
460 
57 
76 
1231 
1205 
1083 
817 
45 
276 
25 
52 
1013 
489 
# and % of 
recurrent 
fallers (≥ 2) 
TT 
TT+VR 
136 (100%) 
146 (100%) 
52 (100%) 
57 (100%) 
20 (100%) 
23 (100%) 
64 (100%) 
66 (100%) 
49 (36·0%) 
62 (42·5%) 
8 (15·4%) 
14 (24·6%) 
6 (30·0%) 
6 (26·1%) 
35 (54·7%) 
42 (63·6%) 
Falls 
incident 
rate (95% 
CI) 
TT 
    
TT+VR 
10·71 
(8·51, 13·47) 
 
11·92 
(9·47, 15·01) 
3·23 
(2·70, 3·86) 
 
 
8·07 
(5·67, 11·49) 
2·85 
(2·20, 3·69) 
 
 
3·30 
( 2·64, 4·14) 
19·23 
(13·39, 27·64) 
 
 
18·26 
(12·79, 26·07) 
8·27 
(5·55, 12·31) 
 
 
6·00 
(4·36, 8·25) 
0·89 
(0·55, 1·44) 
 
 
5·10 
(2·65, 9·80) 
1·28 
(0·58, 2·79) 
 
 
2·35 
(1·11, 4·96) 
16·48 
(9·96, 27·29) 
 
 
8·06 
(5·55, 11·71) 
IR 
comparison         
p-value  
TT vs. 
TT+VR 0·29 <0·001 0·29 0·34 0·03 0·10 0·99 0·01 
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Figure 1:  The V-TIME treadmill training with virtual reality (VR) system.  The system includes a camera based 
motion capture (Microsoft Kinect) and a computer generated simulation. The camera (see the red rectangle) 
records the movement of the participant’s feet (see the red rectangle) while walking on the treadmill. These 
images were transferred into the computer simulation and projected to the patient in real-time time on a large 
screen during training (see the red rectangle). The VR enables the simultaneous and implicit training of motor 
function and the cognitive control needed for safe ambulation including obstacle negotiation, dual tasking, and 
planning.  Progression of the intervention is modulated by the speed of the treadmill, the duration of the 
walking bouts within a given training session, and the size and frequency of the virtual obstacles and the 
distractors.  VR is defined as a “high-end-computer interface that involves real time simulation and interactions 
through multiple sensorial channels"11. 
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Figure 2: Flow of participants through the trial. 282 participants were included in the modified intention to treat analyses, 
(also known as Full Analysis Set – FAS) as reported in the Results (see SM for additional detail). Twenty participants are not 
included in the intention to treat analysis despite randomization; 16 subjects did not start training due to various reasons 
and 4 had less than 3 training sessions, and were excluded from the modified intention to treat plan, based on the the pre-
specified analyses. 245 subjects completed the whole study period (i.e., complete training, assessments at each time 
point, and falls reporting) without major protocol deviations and formed the per-protocol data set. In this paper, all  of the 
results reported are based on the pre-planned, modified intention to treat analyses. In general, the results for the per-
protocol set were similar or slightly better than those in the intention to treat set.  The first study subject was recruited in 
January of 2012. The last subject completed the final follow-up assessment in September of 2015.  
 
 
 
 
Enrollment 
Full Analysis Set (n=136) 
Per Protocol Set (n=119)  
Full Analysis Set (n=146) 
Per Protocol Set (n=126)  
 
Analysis 
ITT 
Assessed for eligibility (n=661) Excluded (n=353) 
 Less than 2 falls (n=118) 
  Age <60  or >90 (n=21) 
  Unable to walk independently (n=29) 
  Severe visual/hearing impairment (n=6) 
  Unstable medication (n=8) 
  Other neurological disorder (n=16) 
  Psychiatric disorder (n=1) 
  Orthopedic condition (n=19) 
  Unable/Unwilling to comply (n=66) 
  Not idiopathic Parkinson’s disease (n=4) 
  Not on anti-Parkinsonian medication (n=6) 
  Other (n=59) 
Allocated to TT intervention (n=148) 
Did not start the training (n=10) 
- Adverse event (n=2) 
Dropped-out subject decision (n=2)   
Allocated to TT+VR intervention (n=154) 
Did not start the training (n=6)  
- Adverse event (n=3)  
Dropped-out subject decision (n=2) 
Allocation 
Randomized (n=302) 
Enrolled (n=308) 
Competed full protocol (n=119) 
Adverse events (n=12) 
Lost to follow-up (n=4) 
Did not comply with training protocol (n=1) 
 
Competed full protocol (n=126) 
Adverse events (n=11) 
Lost to follow-up (n=6) 
Did not comply with training protocol (n=3) 
 
Follow-up 
 
Not meeting inclusion criteria (n=6) 
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Figure 3:  Differences in falls incident rates within and between training arms before and after training.    
Incident rates were similar in the treadmill training with virtual reality (TT+VR) and treadmill training (TT) arms  
pre-training. Subjects in both training arms had fewer falls post training, however, this decrease was significant 
only in the subjects in the TT+VR arm. Subjects in the TT+VR had 42% fewer falls during the 6 month follow-up 
period, compared to those in the TT arm (p=0.033). 95% confidence intervals and incidence rates for the 
subgroups are shown in Table 3. 
 
 
